Please select a video from the list below.
Prostanoids in Pediatric PAH
While IV epoprostenol remains the gold standard for the treatment of advanced pediatric PAH, newer agents may be initiated in carefully selected patients. Dr. Erika Berman Rosenzweig of Columbia University, reviews the use of prostanoids in pediatric PAH patients. Recorded at the UCSF 9th Annual Neonatal and Childhood Pulmonary Vascular Disease Conference.
Recent Video
Most Viewed
Specialties :                    Search :
RESPITE Study Results
RESPITE Study Results Views - 937
ICU Management of PH
ICU Management of PH Views - 142